top of page
vmc-icon_1.png

VMC

Note: This is not medical advice. Our blog posts are for general information purposes only and do not replace medical advice, diagnosis, or treatment. The content is based on careful research and scientific sources, but should not be interpreted as medical advice. Please always consult a doctor with any health-related questions. This article was created with AI assistance and editorially reviewed by the author listed.

(NEWS) Antibiotic resistance & food safety: ECDC report shows progress & challenges

Antibiotic resistance (AMR) in common foodborne pathogens such as Salmonella and Campylobacter remains a significant public health challenge in Europe – but progress is being made. The EU-wide harmonized monitoring program 2023–2024 (ECDC/EFSA) shows that while ciprofloxacin resistance in Campylobacter is so widespread that ciprofloxacin is no longer recommended, 14–19 countries report significant declines in ampicillin/tetracycline resistance in Salmonella (human and animal). At the same time, carbapenemase-producing E. coli have been detected in 8 member states. One Health remains essential – and practical kitchen hygiene is your greatest asset in preventing infections. What exactly do the data show? Which measures are effective? This article explains the evidence-based and practical aspects of everyday life.


What the EU monitoring 2023–2024 shows


The harmonized monitoring program of the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA) for 2023–2024 records antimicrobial resistance (AMR) in Salmonella spp. , Campylobacter jejuni , and Campylobacter coli from humans, livestock (broilers, laying hens, turkeys, pigs, cattle < 1 year old), and meat . Additionally, indicator bacteria ( E. coli , Enterococcus ), ESBL/AmpC/carbapenemase producers, and MRSA are monitored.


Key messages (bullet points):


  • High resistance rates to ampicillin, tetracyclines, sulfonamides in Salmonella / Campylobacter (human & animal) – except laying hens (lower resistance).

  • Ciprofloxacin resistance (a critically important antibiotic for human medicine):

    • Campylobacter : So widespread in Europe that ciprofloxacin is no longer recommended for human infections .

    • Salmonella : Increasing trends in some Member States (especially poultry-associated serovars) – also increasing in laying hens in certain countries.

    • C. jejuni : Increase trends in over 50% of reporting countries (human infections).

  • Combined resistance to critically important antibiotics (CIA) remains rare overall – but : Higher rates are found in certain Salmonella serovars and C. coli in some countries (human & animal).

  • Carbapenemase-producing Salmonella : No evidence in animals; 6 human cases in 2023 , 5 cases in 2024 (primarily blaOXA-48 , also blaOXA-181 , blaNDM-1 , blaIMP-1 ).

  • Carbapenemase-producing E. coli : detected in broilers, turkeys, pigs, calves, pork in 8 Member States – various carbapenemase genes → requires thorough follow-up .

  • Positive Trends (Long-Term Analysis):

    • Salmonella (human): Ampicillin resistance ↘ in 19 countries , Tetracycline resistance ↘ in 14 countries (significant, 10 years).

    • Salmonella (animal, EU level): Tetracycline resistance ↘ in broilers; Ampicillin & Tetracycline ↘ in turkeys.

    • Campylobacter : Erythromycin resistance (first-line therapy) ↘ in several countries (human & animal, last decade).

  • Stabilization/Plateau : Some previously declining resistances (especially indicator E. coli from poultry) have stabilized instead of continuing to decrease → sustained efforts are needed .

  • Significant differences between countries regarding bacteria and antibiotics reflect differences in usage, animal husbandry, and prevention strategies.


Sources: ECDC News story (02/18/2026); ECDC/EFSA EU Summary Report on AMR 2023-2024.


Mechanism: Why is antibiotic resistance in foodborne pathogens a problem?


AMR arises when bacteria develop mechanisms that render antibiotics ineffective – e.g., through enzymes (ESBL, carbapenemase), efflux pumps, target changes (e.g., gyrA mutations in fluoroquinolones).


Key points (bullet points):


  • Transmission chain: animal → food → human (zoonotic pathogens).

  • Selection through antibiotic use in human/veterinary medicine – resistant strains survive and spread.

  • Ciprofloxacin resistance : Frequently caused by gyrA mutations ( Campylobacter , Salmonella ) → Fluoroquinolones ineffective.

  • ESBL/AmpC ( E. coli ): Enzymes that break down beta-lactam antibiotics (including 3rd generation cephalosporins).

  • Carbapenemase ( E. coli , rarely Salmonella ): Enzymes against last-resort antibiotics (carbapenems) → extremely critical.

  • One Health connection : Bacteria/genes circulate between humans, animals, and the environment → coordinated action is needed.

  • Impact : Severe infections (sepsis, gastroenteritis with complications) are more difficult to treat → longer hospital stays, higher mortality, limited treatment options.


What does that mean for you? (Practical relevance)


Good news: Most people do not get a severe AMR infection – and you can massively reduce the risk through simple kitchen hygiene and infection prevention .


Key points (bullet points):


  • Stop cross-contamination : Keep raw meat/poultry strictly separate from ready-to-eat foods (salad, fruit, bread) – separate boards/knives are ideal.

  • Take thorough cooking seriously : Especially poultry should have no pink spots – core temperature at least 70 °C (2 min.).

  • Maintain a stable cold chain : Cool quickly, refrigerate leftovers promptly – do not leave them at room temperature for hours .

  • Handwashing/cleaning contact surfaces : After contact with raw animal products, thoroughly clean hands and surfaces.

  • Use antibiotics responsibly (as a patient): Only as prescribed by a doctor, do not interrupt the course, and do not use leftover tablets later. (Goal: Protect effectiveness – One Health.)

  • Travel/Restaurant – pragmatic check : If cooling/cooking is uncertain (buffet, street food), choose "hot & fresh, thoroughly cooked".

  • Know the warning signs : In severe cases (persistent high fever, blood in stool, severe dehydration), consult a doctor .


Dosage & Application: Are there supplements for AMR?


No – AMR is not a problem that can be solved with supplements. The biggest lever is prevention (hygiene, responsible antibiotic use).

Gut health as an indirect factor (bullet points):


  • Probiotics (e.g., Lactobacillus , Bifidobacterium ): Can stabilize intestinal flora, but do not provide direct AMR protection.

  • Prebiotics (dietary fiber): Support a healthy microbiota – indirectly beneficial for infection resistance.

  • No promises of healing : Supplements do not replace hygiene and the sensible use of antibiotics.

  • Caution : Some probiotics could theoretically carry resistant genes (very rare) – choose quality-tested products.

  • Practical advice : Focus on a balanced diet, hygiene, and safe food preparation .


For whom is this topic particularly relevant?


Target groups (bullet points):


  • Anyone who regularly handles raw meat/poultry (private kitchen, catering).

  • Immunocompromised individuals (higher risk of severe illness if infected).

  • Travelers (especially in regions with high AMR prevalence and unsafe food hygiene).

  • Parents of young children (higher susceptibility to gastroenteritis pathogens).

  • Professionally exposed persons (animal husbandry, meat processing, veterinary medicine, food control).

  • Health-conscious / VMC target group (25–65 years, interested in prevention, evidence-based health optimization).

  • Responder rate : Not applicable (AMR is not a therapeutic approach, but a public health challenge – prevention works for everyone ).


Comparison: How do resistance patterns differ in Europe?


Resistance patterns vary greatly between countries, bacteria, and antibiotics.

Key points (bullet points):


  • Ciprofloxacin resistance Campylobacter : In some countries > 90% , others < 50% (differences in veterinary antibiotic use).

  • Ampicillin resistance Salmonella : Declining in 19 countries (significant, 10 years) – shows: measures are effective .

  • Carbapenemase E. coli : Detection in 8 Member States (animal/meat) – very heterogeneous, partly isolated cases, partly clustered.

  • ESBL- E. coli : Trends show progress in several countries (less ESBL in broilers/turkeys) – but plateau in some countries → continued efforts needed .

  • Positive examples : Countries with strict antibiotic reduction programs (e.g. Scandinavia) often have lower resistance rates .

  • Take-home message : Significant differences → general statements are of limited help; however, trends show that the One Health approach works .


Side effects & contraindications: Are there risks associated with preventive measures?


No – kitchen hygiene has no side effects.

Practical tips (bullet points):


  • Excessive disinfection (e.g., bleach in a private kitchen) is not necessary – thorough cleaning is sufficient.

  • Allergy risk : Some disinfectants can cause skin irritation (especially with excessive use).

  • No risk with reasonable hygiene : hand washing, separate boards, thorough cooking – no contraindications .

  • Antibiotic side effects (when used): Common (GI problems, allergic reactions) – but this is about prevention → ideally avoid antibiotics .

  • Long-term use of hygiene measures : Useful throughout life , no tolerance development.


Limitations of EU monitoring 2023–2024


Always 5 limitations (according to SOP):


  1. Heterogeneity of data collection : Different methods/sample sizes between countries → direct comparisons are limited.

  2. Indicator germs vs. pathogenic agents : Monitoring also detects indicator bacteria ( E. coli ) – these are not automatically disease-causing, but are resistance proxies.

  3. No individual risk predictions : Data are population-level → say nothing about personal risk.

  4. Time lag : Data 2023–2024, report 2026 → current resistances may differ.

  5. Causal relationships unclear : Monitoring shows trends , but not always why resistances change (multifactorial: antibiotic use, hygiene, animal husbandry, genetic factors).


⚠ Important note: This information is for general informational purposes only and does not constitute medical advice. Antibiotic resistance is a complex public health issue. The preventive measures described here (kitchen hygiene, responsible antibiotic use) are evidence-based, but do not replace medical advice in case of suspected serious infection or health problems. Seek immediate medical attention if you experience symptoms such as persistent high fever, blood in your stool, or severe dehydration . Antibiotics should always be used as directed by a doctor.


Sources


Tier 1/Tier 2 Journals & Official Reports:


(Note: DOI 10.2903/j.efsa.2026.9887 is from the EFSA report 2023–2024, published February 2026; ECDC News story from 18.02.2026 is an official source, not a peer-reviewed paper, but a Tier 1 institution; Bonardi/Pitino is a Tier 2 review.)


bottom of page